Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Beta-Sitosterol wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
4 of 5 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
3 of 3 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Beta-Sitosterol and Pygeum have evidence — compare verdict strength side-by-side.
60-130mg daily for prostate; 2-3g for cholesterol
With meals (especially for cholesterol benefits), Divided doses
Standardized phytosterol complex
100-200mg standardized extract daily
Once or twice daily, With or without food
Standardized extract (13-14% sterols)
4-8 weeks
4-6 weeks
6-8 weeks
6-8 weeks
8-12 weeks
Efficacy and mechanisms of Xiangsha Liujunzi Decoction for gastroesophageal reflux disease: A study integrating meta-analysis, network pharmacology and molecular docking
Phytomedicine : international journal of phytotherapy and phytopharmacology (2026) · Meta analysis · n=646
Eight RCTs (n = 646) showed that XSLJZD significantly improved clinical outcomes compared with controls, demonstrating superior overall efficacy and reduced recurrence.
Efficacy and mechanism of Qianjinweijing Decoction for asthma: Integrating systematic review with meta-analysis and network pharmacology
Medicine (2025) · Meta analysis · n=1200
QJWJ is effective in the treatment of asthma, and the therapeutic mechanism may be related to its regulation of inflammation, immunity, and apoptosis.
Genome-wide association study and meta-analysis of phytosterols identifies a novel locus for serum levels of campesterol
Human genomics (2024) · Meta analysis · n=9758
The meta-analysis replicated most of the reported variants, and our study provided significant support for the association of variants in SCARB1 and ABO with sitosterolemia.
What do we know about phytotherapy of benign prostatic hyperplasia?
Life sciences (2015) · Systematic review
On the basis of preclinical studies several mechanisms of action have been postulated, including 5alpha-reductase inhibition, alpha-adrenergic antagonism, dihydrotestosterone and estrogen receptor inhibition.
Phytotherapy of benign prostatic hyperplasia. A minireview
Phytotherapy research : PTR (2014) · Systematic review
Histological BPH, which typically develops after the age of 40 years, ranges in prevalence from >50% at 60 years to as high as 90% by 85 years of age.
Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS)
BMJ clinical evidence (2011) · Systematic review
We found 63 systematic reviews, RCTs, or observational studies that met our inclusion criteria.
Based on meta-analysis of 124 RCTs showing 6-12% LDL reduction at standard doses. Conservative effectiveness scale with optimal intake around 2g/day. No significant effects on HDL or triglycerides observed.
Based on Cochrane review (n=1562) and network meta-analysis showing modest benefits. Evidence quality noted as low-to-moderate due to dated methodology in available RCTs. Most studies used standardized bark extract.
AI-estimated from published studies. Interpret as directional guidance.
Beta-Sitosterol has a higher evidence score (7.5/10 vs 5.5/10) and wins in 2 of 3 categories.
For healthy aging, Pygeum has a higher relevance score (85 vs 80).
No known interactions between Beta-Sitosterol and Pygeum have been documented in our database. However, always consult a healthcare provider before combining supplements.